NCT00251589 2015-03-06A Phase I/II Clinical Trial of Vorinostat in Combination With Erlotinib for Patients With Relapsed/Refractory Non-Small-Cell Lung Cancer (0683-025)Merck Sharp & Dohme LLCPhase 1/2 Terminated23 enrolled 15 charts